A conference for students, by students!
Organised by the St Vincent's Student Society, Biomed Link is an annual one-day conference aimed at providing biomedical students with an opportunity to present their research, and to participate in academic discussions in a less intimidating environment.
Biomed Link will allow attendees to:
- Present their research for peer review,
- Practice answering questions about their research,
- Ask questions and learn about research undertaken outside their field, and
- Interact and network with fellow students from all over Australia.
Registration is FREE and only open to students (Undergraduates, Honours, Masters, PhD) that are enrolled in a biomedical-related course and/ or undertaking a research project in a field of biomedical research.
The Keynote Speakers for the 2019 conference are Professor Andreas Strasser and Dr Danijela Mirosa.
Professor Andreas Strasser is a is a cancer researcher at the Walter and Eliza Hall Institute trained in cell biology, immunology and molecular oncology. He has made major contributions to the discoveries that defects in cell death can cause cancer, autoimmune disease and impair the response of cancers to chemotherapy. His current work aims to reach a detailed understanding of the molecular control of programmed cell death. His team is exploiting this knowledge to develop novel treatments for cancer and autoimmune diseases that directly activate the cell death machinery.
Dr Danijela Mirosa is the Head of Strategy & Patient Services for Oceania Cluster, Takeda Pharmaceuticals. She has over 15 years of “bench to business” biopharmaceutical experience across Rare and Specialty disease areas. Following the completion of her PhD, Dani spent more than 6 years as a translational research scientist in the Australian biotechnology sector, specializing in experimental recombinant antibody drugs against oncology and inflammatory disease targets. Having gained this experience in early stage drug development, she then expanded her career into the commercial side of the industry. She has held numerous marketing roles across diverse therapeutic areas such as Immunology, Neurology, Haemophilia, Oncology and Ophthalmology, and more recently she was Head of Strategy & Operations, Australia/New Zealand for Shire prior to its acquisition by Takeda in early 2019. Her qualifications include a PhD in Biomedicine and an MBA from Melbourne Business School.
Registration and Presentation
For BML 2019 registration and abstract submission follow the links below.
For oral, poster and 3MT guidelines follow the links below.
Follow us on social media!